Table 1.
Characteristics of the study population
| Characteristics | Control (N = 10) | UC (N = 7) | p Value |
|---|---|---|---|
| Male/female (%) | 5/5(50/50) | 3/4(43/57) | p > 0.05 |
| Median (IQR) age (years) | 47(31–50.5) | 47(31–50.5) | p > 0.05 |
| Median (IQR) duration of disease (years) | NA | 5(2–6.5) | NA |
| Median (IQR) BMI | 25(23–26.5) | 26(21–27) | p > 0.05 |
| Medication | NA | NA | |
| 5-Aminosalicylic acid (%) | 7(100) | ||
| Azathioprine (%) | 4(57) | ||
| Corticosteroids (%) | 2(29) | ||
| Anti-TNF (%) | 1(19) | ||
| Disease activity | NA | NA | |
| Remission (SCCAI Score < 5) | 3(43) | ||
| Active (SCCAI Score ≥ 5) | 4(57) |
Groups were compared by non-parametric analyses
BMI body mass index, NA not applicable
p < 0.05 was considered significant